Viral vectors for vaccination R&D

Viral vectors have come into the focus of modern vaccine developments.Efficient gene transduction and antigene expression help elicit a robust T-cell response that in turn can lead to strong elimination of pathogens.

The SIRION technology platform offers versatile options to identify and optimize the best possible approach for YOUR vaccine R&D.

HOT TOPICS:

BAC technology to build new viral vector systems from scratch.

Serotype Ad19a/64to transduce antigen-presenting dendritic cells.

CONTACT US – Discuss how we can add value to your vaccination R&D.